omniture
logo
Search
Kangpu Biopharmaceuticals, Ltd.
Media Room

Latest News

rss

Kangpu Biopharmaceuticals to Present Preclinical Efficacy Data of KPG-818 in Crohn's Disease at the 19th Congress of ECCO (IND Application for Phase II in Progress)

HEFEI, China, Feb. 20, 2024 /PRNewswire/ -- Kangpu Biopharmaceuticals, a clinical-stage company ded...

2024-02-20 20:00 1044

Kangpu Announces First Patient Dosed in the US Phase IIa Clinical Trial of NeoMIDES™ Molecular Glue KPG-818 in Systemic Lupus Erythematosus

SHANGHAI, June 12, 2022 /PRNewswire/ -- Kangpu Biopharmaceuticals, a clinical-stage company based i...

2022-06-13 09:00 1520

Kangpu Biopharmaceuticals Initiates Phase Ib/IIa Clinical Trial of KPG-818 in Systemic Lupus Erythematosus

SHANGHAI, Nov. 17, 2020 /PRNewswire/ -- Kangpu Biopharmaceuticals, a clinical-stage company based i...

2020-11-17 09:00 2246

Kangpu to Present Two Posters at the 2020 American Association for Cancer Research (AACR) Annual Meeting

SHANGHAI, June 17, 2020 /PRNewswire/ -- Kangpu Biopharmaceuticals, a clinical-stage company focused...

2020-06-17 21:00 1315

Kangpu Biopharmaceuticals Successfully Completed Phase I Study of Novel CRL4-CRBN Modulator KPG-818 in the U.S.

SHANGHAI, Oct. 11, 2019 /PRNewswire/ -- Kangpu Biopharmaceuticals announced today that it has succe...

2019-10-11 13:00 1318